000 | 01401 a2200373 4500 | ||
---|---|---|---|
005 | 20250517135914.0 | ||
264 | 0 | _c20170329 | |
008 | 201703s 0 0 eng d | ||
022 | _a1756-1833 | ||
024 | 7 |
_a10.1136/bmj.j337 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aSpelsberg, Angela | |
245 | 0 | 0 |
_aContribution of industry funded post-marketing studies to drug safety: survey of notifications submitted to regulatory agencies. _h[electronic resource] |
260 |
_bBMJ (Clinical research ed.) _cFeb 2017 |
||
300 |
_aj337 p. _bdigital |
||
500 | _aPublication Type: Journal Article | ||
650 | 0 | 4 |
_aAdverse Drug Reaction Reporting Systems _xstatistics & numerical data |
650 | 0 | 4 |
_aDrug Approval _xeconomics |
650 | 0 | 4 |
_aDrug Industry _xeconomics |
650 | 0 | 4 |
_aDrug-Related Side Effects and Adverse Reactions _xclassification |
650 | 0 | 4 |
_aFinancial Management _xmethods |
650 | 0 | 4 | _aGermany |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 | _aOutcome and Process Assessment, Health Care |
650 | 0 | 4 |
_aProduct Surveillance, Postmarketing _xeconomics |
700 | 1 | _aPrugger, Christof | |
700 | 1 | _aDoshi, Peter | |
700 | 1 | _aOstrowski, Kerstin | |
700 | 1 | _aWitte, Thomas | |
700 | 1 | _aHüsgen, Dieter | |
700 | 1 | _aKeil, Ulrich | |
773 | 0 |
_tBMJ (Clinical research ed.) _gvol. 356 _gp. j337 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1136/bmj.j337 _zAvailable from publisher's website |
999 |
_c26859593 _d26859593 |